DOYLE WILLIAM F
SEC CIK 1194459 · EDGAR
BoughtSold
Most active insiders at NVCR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DOYLE WILLIAM F | Executive COB, Dir | — | $933.1K |
| 2 | Leonard Frank X | EVP, Pres, Novocure Oncology | — | $919.8K |
| 3 | Paravasthu Mukund | COO | — | $693.8K |
| 4 | Weinberg Uri | Chf Medical, Innovation Ofr | — | $232.2K |
| 5 | Brackmann Christoph | CFO | — | $85.3K |
| 6 | Stafford Kristin | Dir | — | $46.4K |
| 7 | Ocean Allyson J | Dir | — | $46.4K |
| 8 | Scannell Timothy J | Dir | — | $46.4K |
| 9 | VERNON W ANTHONY | Dir | — | $46.4K |
| 10 | Hung David | Dir | — | $46.4K |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-05 | 2026-03-03 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive COB, Dir | A - Grant | $0.00 | +400.3K | 200.0K | New | $0 |
| DM | 2026-03-05 | 2026-03-03 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive COB, Dir | S - Sale | $12.98 | -71.9K | 349.7K | -17% | -$933.1K |
| 2024-12-03 | 2024-11-29 | ELAN | Elanco Animal Health Inc | DOYLE WILLIAM F | Dir | A - Grant | $0.00 | +18.2K | 94.5K | +24% | $0 | |
| 2024-05-23 | 2024-05-21 | ELAN | Elanco Animal Health Inc | DOYLE WILLIAM F | Dir | P - Purchase | $16.98 | +15.0K | 76.3K | +24% | +$254.7K | |
| 2024-03-12 | 2024-03-08 | ELAN | Elanco Animal Health Inc | DOYLE WILLIAM F | Dir | P - Purchase | $16.30 | +15.0K | 61.3K | +32% | +$244.5K | |
| 2023-12-04 | 2023-11-30 | ELAN | Elanco Animal Health Inc | DOYLE WILLIAM F | Dir | A - Grant | $0.00 | +20.4K | 46.3K | +78% | $0 | |
| 2022-12-02 | 2022-11-30 | ELAN | Elanco Animal Health Inc | DOYLE WILLIAM F | Dir | A - Grant | $0.00 | +18.6K | 26.0K | +255% | $0 | |
| 2022-08-03 | 2022-08-02 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive COB, Dir | S - Sale | $69.66 | -837 | 551.2K | -0.2% | -$58.3K | |
| 2022-03-09 | 2022-03-08 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive COB, Dir | S - Sale | $70.10 | -2,385 | 552.0K | -0.4% | -$167.2K | |
| 2021-12-02 | 2021-11-30 | ELAN | Elanco Animal Health Inc | DOYLE WILLIAM F | Dir | A - Grant | $0.00 | +7,307 | 7,307 | New | $0 | |
| 2021-08-04 | 2021-08-02 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive COB, Dir | S - Sale | $149.38 | -995 | 554.4K | -0.2% | -$148.6K |
Purchase Sale Sale after option exercise All abbreviations